المساهمون: Yuna Kim, Jae Seung Lee, Hye Won Lee, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Myung Ji Goh, Wonseok Kang, Seung Up Kim, Kim, Do Young

مصطلحات موضوعية: Antineoplastic Agents* / adverse effects, Carcinoma, Hepatocellular* / pathology, Humans, Liver Neoplasms* / pathology, Middle Aged, Nivolumab / adverse effects, Phenylurea Compounds / adverse effects, Sorafenib / adverse effects, Treatment Failure

العلاقة: EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY; J00821; OAK-2022-10721; OAK-2022-10722; OAK-2022-10723; OAK-2022-10724; OAK-2022-10725; OAK-2022-10726; OAK-2022-10727; OAK-2022-10728; https://ir.ymlib.yonsei.ac.kr/handle/22282913/193516Test; https://journals.lww.com/eurojgh/Fulltext/2023/02000/Sorafenib_versus_nivolumab_after_lenvatinib.7.aspxTest; T202300160; EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, Vol.35(2) : 191-197, 2023-02

الإتاحة: https://doi.org/10.1097/MEG.0000000000002466Test
https://ir.ymlib.yonsei.ac.kr/handle/22282913/193516Test
https://journals.lww.com/eurojgh/Fulltext/2023/02000/Sorafenib_versus_nivolumab_after_lenvatinib.7.aspxTest

المساهمون: Junhwan Kim, Joseph J Noh, Tae Kyoung Lee, Se Ik Kim, Jung-Yun Lee, Jeong-Won Lee, Jae-Weon Kim, Lee, Jung-Yun

مصطلحات موضوعية: Adult, Aged, Antibodies, Monoclonal, Humanized, Endometrial Neoplasms* / drug therapy, Female, Humans, Middle Aged, Neoplasm Recurrence, Local / drug therapy, Phenylurea Compounds / adverse effects, Quinolines* / adverse effects, Retrospective Studies, Endometrial neoplasm, Lenvatinib, Pembrolizumab, Prognosis, Toxicity, Treatment

العلاقة: GYNECOLOGIC ONCOLOGY; J00956; OAK-2022-06071; https://ir.ymlib.yonsei.ac.kr/handle/22282913/191427Test; https://www.sciencedirect.com/science/article/pii/S0090825822001408?via%3DihubTest; T202205447; GYNECOLOGIC ONCOLOGY, Vol.165(2) : 369-375, 2022-05

الإتاحة: https://doi.org/10.1016/j.ygyno.2022.02.020Test
https://ir.ymlib.yonsei.ac.kr/handle/22282913/191427Test
https://www.sciencedirect.com/science/article/pii/S0090825822001408?via%3DihubTest

المساهمون: Bo Hyun Kim, Su Jong Yu, Wonseok Kang, Sung Bum Cho, Soo Young Park, Seung Up Kim, Do Young Kim, Kim, Do Young

مصطلحات موضوعية: Carcinoma, Hepatocellular* / drug therapy, Consensus, Drug-Related Side Effects and Adverse Reactions* / therapy, Humans, Liver Neoplasms* / drug therapy, Phenylurea Compounds* / adverse effects, Protein Kinase Inhibitors / adverse effects, Quinolines* / adverse effects, adverse events, hepatocellular carcinoma, lenvatinib, management

العلاقة: JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY; J01417; OAK-2022-02430; https://ir.ymlib.yonsei.ac.kr/handle/22282913/189289Test; T202202168; JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Vol.37(3) : 428-439, 2022-03

الإتاحة: https://doi.org/10.1111/jgh.15727Test
https://ir.ymlib.yonsei.ac.kr/handle/22282913/189289Test

المساهمون: Min Jin Lee, Sung Won Chang, Ji Hoon Kim, Young-Sun Lee, Sung Bum Cho, Yeon Seok Seo, Hyung Joon Yim, Sang Youn Hwang, Hyun Woong Lee, Young Chang, Jae Young Jang, Lee, Hyun Woong

مصطلحات موضوعية: Adult, Age Factors, Aged, 80 and over, Antineoplastic Agents / administration & dosage, Antineoplastic Agents / adverse effects, Antineoplastic Agents / therapeutic use, Antineoplastic Combined Chemotherapy Protocols / therapeutic use, Carcinoma, Hepatocellular / drug therapy, Hepatocellular / mortality, Hepatocellular / pathology, Female, Humans, Kaplan-Meier Estimate, Liver Neoplasms / drug therapy, Liver Neoplasms / mortality, Liver Neoplasms / pathology, Male, Middle Aged, Patient Acuity, Phenylurea Compounds / administration & dosage, Phenylurea Compounds / adverse effects, Phenylurea Compounds / therapeutic use, Progression-Free Survival, Pyridines / administration & dosage, Pyridines / adverse effects, Pyridines / therapeutic use, Republic of Korea, Retrospective Studies

العلاقة: INVESTIGATIONAL NEW DRUGS; J01184; OAK-2022-05244; https://ir.ymlib.yonsei.ac.kr/handle/22282913/191047Test; https://link.springer.com/article/10.1007/s10637-020-00977-4Test; T9992022453; INVESTIGATIONAL NEW DRUGS, Vol.39(1) : 260-268, 2021-02

الإتاحة: https://doi.org/10.1007/s10637-020-00977-4Test
https://ir.ymlib.yonsei.ac.kr/handle/22282913/191047Test

المساهمون: Takuji Okusaka, Kenji Ikeda, Masatoshi Kudo, Richard Finn, Shukui Qin, Kwang-Hyub Han, Ann-Lii Cheng, Fabio Piscaglia, Masahiro Kobayashi, Max Sung, Minshan Chen, Lucjan Wyrwicz, Jung-Hwan Yoon, Zhenggang Ren, Kalgi Mody, Corina Dutcus, Toshiyuki Tamai, Min Ren, Seiichi Hayato, Hiromitsu Kumada, Han, Kwang Hyup

مصطلحات موضوعية: Adult, Aged, 80 and over, Antineoplastic Agents / adverse effects, Antineoplastic Agents / pharmacology, Antineoplastic Agents / therapeutic use, Body Weight / drug effects, Carcinoma, Hepatocellular / drug therapy, Dose-Response Relationship, Drug, Female, Humans, Liver Neoplasms / complications, Liver Neoplasms / drug therapy, Male, Middle Aged, Phenylurea Compounds / adverse effects, Phenylurea Compounds / pharmacology, Phenylurea Compounds / therapeutic use, Quinolines / adverse effects, Quinolines / pharmacology, Quinolines / therapeutic use, Sorafenib / adverse effects, Sorafenib / pharmacology, Sorafenib / therapeutic use, Treatment Outcome, Body weight, Dosing, Hepatocellular carcinoma

العلاقة: JOURNAL OF GASTROENTEROLOGY; J01416; OAK-2022-04247; https://ir.ymlib.yonsei.ac.kr/handle/22282913/190430Test; T202126062; JOURNAL OF GASTROENTEROLOGY, Vol.56(6) : 570-580, 2021-06

الإتاحة: https://doi.org/10.1007/s00535-021-01785-0Test
https://ir.ymlib.yonsei.ac.kr/handle/22282913/190430Test

المساهمون: Robert Motzer, Boris Alekseev, Sun-Young Rha, Camillo Porta, Masatoshi Eto, Thomas Powles, Viktor Grünwald, Thomas E Hutson, Evgeny Kopyltsov, María J Méndez-Vidal, Vadim Kozlov, Anna Alyasova, Sung-Hoo Hong, Anil Kapoor, Teresa Alonso Gordoa, Jaime R Merchan, Eric Winquist, Pablo Maroto, Jeffrey C Goh, Miso Kim, Howard Gurney, Vijay Patel, Avivit Peer, Giuseppe Procopio, Toshio Takagi, Bohuslav Melichar, Frederic Rolland, Ugo De Giorgi, Shirley Wong, Jens Bedke, Manuela Schmidinger, Corina E Dutcus, Alan D Smith, Lea Dutta, Kalgi Mody, Rodolfo F Perini, Dongyuan Xing, Toni K Choueiri, Rha, Sun Young

مصطلحات موضوعية: Adult, Aged, 80 and over, Antibodies, Monoclonal, Humanized / administration & dosage, Humanized / adverse effects, Antineoplastic Agents / adverse effects, Antineoplastic Agents / therapeutic use, Antineoplastic Combined Chemotherapy Protocols / adverse effects, Antineoplastic Combined Chemotherapy Protocols / therapeutic use, Carcinoma, Renal Cell / drug therapy, Renal Cell / mortality, Everolimus / administration & dosage, Everolimus / adverse effects, Female, Humans, Kidney Neoplasms / drug therapy, Kidney Neoplasms / mortality, Male, Middle Aged, Phenylurea Compounds / administration & dosage, Phenylurea Compounds / adverse effects, Programmed Cell Death 1 Receptor / antagonists & inhibitors, Progression-Free Survival, Protein Kinase Inhibitors / therapeutic use, Quinolines / administration & dosage, Quinolines / adverse effects, Sunitinib / adverse effects

العلاقة: NEW ENGLAND JOURNAL OF MEDICINE; J02371; OAK-2021-06182; https://ir.ymlib.yonsei.ac.kr/handle/22282913/185460Test; T202104165; NEW ENGLAND JOURNAL OF MEDICINE, Vol.384(14) : 1289-1300, 2021-04

الإتاحة: https://doi.org/10.1056/NEJMoa2035716Test
https://ir.ymlib.yonsei.ac.kr/handle/22282913/185460Test

المؤلفون: Eroukhmanoff, Juliette, Castinetti, Frederic, Penel, Nicolas, Salas, Sébastien

المساهمون: CHU Lille, Université de Lille, 547835, METRICS : Evaluation des technologies de santé et des pratiques médicales - ULR 2694, Evaluation des technologies de santé et des pratiques médicales - ULR 2694 METRICS

مصطلحات موضوعية: Chordoma, Auto-immune thyroid dysfunction, Tyrosine kinase inhibitors, Mesh:Phenylurea Compounds/adverse effects, Mesh:Graves Disease/chemically induced, Mesh:Humans, Mesh:Imatinib Mesylate/adverse effects, Mesh:Male, Mesh:Middle Aged, Mesh:Neoplasm Recurrence, Mesh:Local/drug therapy, Mesh:Niacinamide/adverse effects, Mesh:Chordoma/drug therapy, Mesh:Antineoplastic Agents/adverse effects, Mesh:Protein Kinase Inhibitors/adverse effects, Mesh:Niacinamide/analogs & derivatives

وصف الملف: application/octet-stream; application/rdf+xml; charset=utf-8; application/pdf

العلاقة: BMC Cancer; http://hdl.handle.net/20.500.12210/17119Test

الإتاحة: https://doi.org/20.500.12210/17119Test
https://hdl.handle.net/20.500.12210/17119Test

المؤلفون: Aydemirli, M D, Kapiteijn, E, Ferrier, K R M, Ottevanger, P B, Links, T P, van der Horst-Schrivers, A N A, Broekman, K E, Groenwold, R H H, Zwaveling, J

المصدر: Aydemirli , M D , Kapiteijn , E , Ferrier , K R M , Ottevanger , P B , Links , T P , van der Horst-Schrivers , A N A , Broekman , K E , Groenwold , R H H & Zwaveling , J 2020 , ' Effectiveness and toxicity of lenvatinib in refractory thyroid cancer : Dutch real-life data ' , European Journal of Endocrinology , vol. 182 , no. 2 , pp. 131-138 . https://doi.org/10.1530/EJE-19-0763Test

مصطلحات موضوعية: Adult, Aged, 80 and over, Antineoplastic Agents/therapeutic use, Disease-Free Survival, Female, Humans, Kaplan-Meier Estimate, Male, Middle Aged, Phenylurea Compounds/adverse effects, Quinolines/adverse effects, Retrospective Studies, Thyroid Neoplasms/drug therapy

وصف الملف: application/pdf

العلاقة: https://research.rug.nl/en/publications/95846c5d-1a76-4caa-926e-65a4053d0ad1Test

الإتاحة: https://doi.org/10.1530/EJE-19-0763Test
https://hdl.handle.net/11370/95846c5d-1a76-4caa-926e-65a4053d0ad1Test
https://research.rug.nl/en/publications/95846c5d-1a76-4caa-926e-65a4053d0ad1Test
https://pure.rug.nl/ws/files/116876227/Effectiveness_and_toxicity_of_lenvatinib_in_refractory_thyroid_cancer_Dutch_real_life_data.pdfTest

المؤلفون: Aanes, Siv Gyda, Nieder, Carsten, Prytz, Jan, Odeh, Francis

المصدر: Tidsskrift for Den Norske Laegeforening. 138(17):1632

المساهمون: College of Medicine, Dept. of Internal Medicine, Sangheun Lee, Jung Hyun Kang, Do Young Kim, Sang Hoon Ahn, Jun Yong Park, Beom Kyung Kim, Seung Up Kim, Kwang-Hyub Han, Kim, Do Young, Kim, Beom Kyung, Kim, Seung Up, Park, Jun Yong, Ahn, Sang Hoon, Han, Kwang Hyup

مصطلحات موضوعية: Adult, Aged, 80 and over, Carcinoma, Hepatocellular/drug therapy, Hepatocellular/pathology, Chemoembolization, Therapeutic/methods, Disease Progression, Disease-Free Survival, Female, Humans, Liver Neoplasms/drug therapy, Liver Neoplasms/pathology, Male, Middle Aged, Neoplasm Invasiveness, Niacinamide/administration & dosage, Niacinamide/adverse effects, Niacinamide/analogs & derivatives, Niacinamide/pharmacology, Phenylurea Compounds/administration & dosage, Phenylurea Compounds/adverse effects, Phenylurea Compounds/pharmacology, Portal Vein/pathology, Prognosis, Protein Kinase Inhibitors/therapeutic use, Retrospective Studies, Treatment Failure, Treatment Outcome

العلاقة: HEPATOLOGY INTERNATIONAL; J00986; OAK-2017-02019; https://ir.ymlib.yonsei.ac.kr/handle/22282913/154399Test; https://link.springer.com/article/10.1007%2Fs12072-017-9792-3Test; T201701400; HEPATOLOGY INTERNATIONAL, Vol.11(3) : 292-299, 2017

الإتاحة: https://doi.org/10.1007/s12072-017-9792-3Test
https://ir.ymlib.yonsei.ac.kr/handle/22282913/154399Test